Lopinavir and Ritonavir
These highlights do not include all the information needed to use LOPINAVIR AND RITONAVIR TABLETS safely and effectively. See full prescribing information for LOPINAVIR AND RITONAVIR TABLETS. LOPINAVIR AND RITONAVIR tablets, for oral use Initial U.S. Approval: 2000
f63db7e1-71cd-325c-e053-2995a90aa071
HUMAN PRESCRIPTION DRUG LABEL
Mar 6, 2023
NuCare Pharmaceuticals,Inc.
DUNS: 010632300
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Lopinavir and Ritonavir
Product Details
FDA regulatory identification and product classification information